glutamine has been researched along with Neoplasms, Nerve Sheath in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, JMH; Ali, ES; Alt, J; Asara, JM; Ben-Sahra, I; Krecmerova, M; Lemberg, KM; Majer, P; Nuha, N; Peters, DE; Pratilas, CA; Rais, R; Slusher, BS; Staedtke, V; Wu, Y; Zhao, L | 1 |
| Aguilar, JMH; Alt, J; Blakeley, JO; Brayton, C; Dash, RP; Lam, J; Lemberg, KM; Majer, P; Nedelcovych, MT; Rais, R; Rodriguez, C; Slusher, BS; Tenora, L; Veeravalli, V; Wu, Y; Zhao, L | 1 |
2 other study(ies) available for glutamine and Neoplasms, Nerve Sheath
| Article | Year |
|---|---|
Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor.
Topics: Animals; Antimetabolites; Cell Line, Tumor; Glutamine; Humans; Mice; Nerve Sheath Neoplasms; Neurofibrosarcoma | 2023 |
The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Female; Glutamine; Humans; Male; Mice; Nerve Sheath Neoplasms; Prodrugs; Xenograft Model Antitumor Assays | 2020 |